CONTINGENT VALUE RIGHTS AGREEMENT by and between CARTESIAN THERAPEUTICS, INC. and EQUINITI TRUST COMPANY, LLC, as Trustee Dated as of December 6, 2023Contingent Value Rights Agreement • December 8th, 2023 • Cartesian Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 6, 2023, by and between Cartesian Therapeutics, Inc., a Delaware corporation formerly known as Selecta Biosciences, Inc. (the “Company”), and Equiniti Trust Company, LLC, a New York limited liability trust company, as trustee, in favor of each person who from time to time holds one or more Contingent Value Rights (the “Securities” or “CVRs”) to receive cash payments in the amounts and subject to the terms and conditions set forth herein.
